Click on headlines below to download research

Termination of coverage
Termination of coverage - AlzeCure Pharma | 31/10/2022

Edison Investment Research is terminating coverage on Mercia Asset Management (MERC), Bloc Ventures (unlisted), YOC (YOC.DE), Genuit Group (GEN), AlzeCure…

Progress on all fronts and evolving into Phase II
AlzeCure Pharma | 30/05/2022

With fresh funding in place and the FDA’s response to a pre-IND application, AlzeCure is evolving into a Phase II company with the initiation of…

Edison Open House Healthcare 2022
AlzeCure Pharma: Edison Open House Healthcare 2022 | 09/02/2022

AlzeCure Pharma is a clinical-stage biotech company based in Sweden focused on developing small molecule drugs for the treatment of Alzheimer’s disease…